As of 2026-02-07, the Intrinsic Value of Kezar Life Sciences Inc (KZR) is -48.86 USD. This KZR valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.12 USD, the upside of Kezar Life Sciences Inc is -898.37%.
Based on its market price of 6.12 USD and our intrinsic valuation, Kezar Life Sciences Inc (KZR) is overvalued by 898.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -48.86 - -48.86 | -48.86 | -898.37% |
| P/E | (143.06) - (176.09) | (170.03) | -2878.3% |
| DDM - Stable | (88.13) - (395.57) | (241.85) | -4051.8% |
| DDM - Multi | (3.71) - (12.70) | (5.71) | -193.2% |
| Market Cap (mil) | 44.80 |
| Beta | 0.88 |
| Outstanding shares (mil) | 7.32 |
| Enterprise Value (mil) | 12.52 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.99% |
| Cost of Debt | 5.00% |
| WACC | 8.00% |